Dr. Antonia Sepulveda co-authored a guideline publication from the College of American Pathologists in collaboration with the Association for Molecular Pathology and Fight Colorectal Cancer, that addresses the use of mismatch repair and microsatellite instability testing for immune checkpoint inhibitor therapy, as guiding biomarkers in immune-oncology.
